New-Onset Diabetes in Covid-19
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
Chee, Y. J., Ng, S. J. H., & Yeoh, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108166 · Cited by 287
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Ren, H., Yang, Y., Wang, F., Yan, Y., Shi, X., Dong, K., Yu, X., & Zhang, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01035-2 · Cited by 200
Cited by
Items 801–808 of 808
Okyere, E., Marfoh, K., Goundar, R., Makutu, L., & Kabukeinamala, D. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1846673
Gowrinathan, T. G., Rupa Devi, P., Revathy, R., Nehaashri, K., Varadarajan, P., & Anuradha, D. (2026) · Cureus · doi:10.7759/cureus.116704
Prevalência e interferências da covid-19 na saúde de pessoas com diabetes mellitus tipo 2
Kich, J., TERRES, H. B., Possuelo, L. G., VESCOVI, C., & Valim, A. R. D. M. (2026) · Saúde (Santa Maria) · doi:10.5902/2236583485188
Szydlarska, D., Jewczak, M., Ciechomska, M. Z., Śniegowski, M., Orlewska, K., Orlewska, E., & Śliwczyński, A. M. (2026) · Medical Studies · doi:10.5114/ms/218690
Using genetics and cell models to understand virus-host interactions in the airways
Shrees, C. (2026) · Nottingham ePrints (University of Nottingham)
Global burden of type 2 diabetes attributable to SARS-CoV-2 infection
Li, J., Liu, G., Yang, J., Ma, H., Wang, X., Jiang, Z., Liang, Y., & He, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1969341
Zahro, F. (2022) · Universitas Airlangga Repository (Universitas Airlangga)
Cattledge, G. H., Luwoye, T. N., Ogionwo, G. E. B., Ross, N. B., & Bremmer, Z. M. (2026) · Journal of the Georgia Public Health Association · doi:10.20429/jgpha.2026.120103
Metadata
- Authors
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
- Affiliations
- King's College London (GB)
- Monash University (AU)
- Imperial College London (GB)
- Technische Universität Dresden (DE)
- University of Colorado Anschutz (US)
- Agostino Gemelli University Polyclinic (IT)
- Nanyang Technological University (SG)
- University of Pisa, Pisa, Italy
- Peking University (CN)
- Kings Health Partners (GB)
- University of Michigan (US)
- University of Leicester (GB)
- Université de Yaoundé I (CM)
- University of Montpellier, Montpellier, France
- Corresponding author
- Rubino, Francesco
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 789-790
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7304415
- OpenAlex
- W3035586023
- Cited by
- 801
- References
- 5
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Transcampus of Technische Universität Dresden & King’s College London
- King’s College London, London, UK and Monash University, Melbourne Australia
- Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.